The more the use of AI in healthcare and healthcare research becomes mainstream, the more the risks associated with AI-powered analysis evolve — and the greater the potential for breakdowns in consumer trust.
The CDC has engaged the California-based health system's Vaccine Study Center to conduct an analysis of its Covid-19 vaccine data with the aim of pinpointing adverse events and reactions. The collaboration will continue for the next three years.
If you’re helping clients navigate big changes—from the surge in GLP-1 demand to AI to the growing pressure to demonstrate ROI – we want your thoughts.